Engineered to comply with Swissmedic regulations and optimized for advanced biopharmaceutical formulations.
As a global hub for chemical innovation and biopharmaceutical manufacturing, Switzerland hosts some of the world's most sophisticated life sciences clusters. From the multinational giants in Basel to the cutting-edge biotech spin-offs in the Swiss Lemanic Arc and Zurich, the demand for ultra-pure chemical intermediates has never been more critical. The Cholic Acid (CA) series—comprising primary and secondary bile acids like Chenodeoxycholic Acid (CDCA), Deoxycholic Acid (DCA), and conjugated derivatives such as Tauroursodeoxycholic Acid (TUDCA)—holds a vital place within this ecosystem.
In Swiss diagnostics laboratories, sodium deoxycholate and sodium cholate are heavily utilized as highly selective, mild detergents. Their unique amphipathic structure makes them indispensable for cellular lysis, membrane protein extraction, and ELISA assay formulation. In the burgeoning field of nanomedicine and drug-delivery systems, Swiss researchers are increasingly looking toward bile acid-modified liposomes (bilosomes). These systems exhibit superior stability under physiological conditions and can bypass traditional biological barriers, paving the way for next-generation oral protein therapeutics and vaccine platforms.
Ursodeoxycholic Acid (UDCA) and TUDCA have transitioned from traditional therapeutic agents to frontiers in neuroprotection. With the European Union and Switzerland accelerating approvals for orphan drug classifications, cholic acid derivatives are being investigated for treating neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, and Alzheimer's. Chenlv Herb, with its modern manufacturing platform, is uniquely positioned to supply the Swiss market with raw materials that exhibit trace-level organic impurities, allowing researchers to skip complex secondary purification steps.
Operating under the rigorous purview of Swissmedic guidelines, Swiss pharmaceutical procurement mandates extensive documentation, including GMP certificates, Heavy Metal analyses, and detailed residual solvent limits in compliance with the European Pharmacopoeia (EP). Chengdu Chenlv Herb's dedicated quality management system offers complete analytical backing to ensure seamless customs clearance and approval processes inside Switzerland.
Established in 2012, Chengdu Chenlv Herb Co., Ltd. (referred to as "Chenlv Herb") is a pioneering high-tech enterprise specializing in the research, development, production, and global sales of premium botanical extracts and natural pharmaceutical ingredients. With over a decade of chemical refinement and technological evolution, our core competencies have expanded into the large-scale extraction and semi-synthesis of the bile acid series (Cholic Acid, CDCA, UDCA, and conjugated salts). We are fully committed to supplying high-purity, highly active, and exceptionally stable natural raw materials to industries ranging from pharmaceuticals and health supplements to functional cosmetics and advanced animal nutrition.
Bile acid chemistry requires stringent reaction controls to avoid isomeric impurities. Chenlv Herb utilizes a dual-pathway technological roadmap combining sustainable natural extraction with precise bio-catalytic/chemical semi-synthesis.
Starting with strictly inspected bovine/porcine bile sources, our processing lines employ high-pressure extraction and multi-stage crystallization techniques. The isolation of high-purity Cholic Acid (CA) serves as the foundation for the entire derivative portfolio. Our optimization algorithms control the temperature-dependent solubility curves, securing yields that surpass standard industry metrics.
One of the primary challenges in supplying Deoxycholic Acid (DCA) and Chenodeoxycholic Acid (CDCA) is the elimination of unwanted stereoisomers. Through optimized column chromatography and organic recrystallization cycles, Chenlv Herb maintains chromatographic purities exceeding 99.0% by HPLC. Our processes actively isolate and eliminate trace bile acids, such as lithocholic acid (LCA), known for biological toxicity.
For research applications in Swiss universities and bio-labs, conjugated salts like Taurochenodeoxycholic Acid Sodium Salt require peptide-bond formation between the bile acid carboxyl group and the amine group of taurine. We utilize peptide coupling reagents under optimized physiological pH environments, preventing polymerization and degradation of the starting molecules.
Why Swiss pharmaceutical companies and international buyers partner with Chenlv Herb.
How our bile acid derivatives and natural active ingredients serve global sectors.
Driven by the concept of "homology of medicine and food" and modern wellness trends, our extracts serve as vital active ingredients in hepatoprotective supplements and metabolic health formulations.
READ MORE
From time-tested therapeutic formulas to innovative drug discovery pipelines, our high-purity bile acids serve as key APIs and excipients in modern medicine.
READ MORE
Aligned with the consumer shift toward clean, biocompatible beauty, our ingredients provide soothing, protective, and emulsifying support for advanced dermatological skincare lines.
READ MORE
Bile acids are showing immense value in optimizing lipid absorption, enhancing production performance, and supporting gut health across intensive livestock and aquaculture applications.
READ MOREChenlv Herb provides one-stop contract manufacturing services customized for Swiss and global partners.
Consultation to clarify precise chemical and volume requirements.
Tailored pricing plans sent to your procurement team within 24 hours.
Formalizing pricing, delivery parameters, and non-disclosure agreements.
Formulating lab-scale sample batches for Swiss client evaluation.
Scheduling our GMP-aligned production lines upon sample approval.
Complete batch analysis (COA, HPLC, heavy metal screening).
Prompt delivery from our facilities straight to your warehouse in Switzerland.
Our operations comply with stringent global regulatory standards: ISO9001, ISO22000, HALAL, KOSHER, and FDA.
Stay updated with our latest biotechnology integrations, market forecasts, and chemical supply trends.
With natural raw material price fluctuations in China drawing significant industry attention, exploring the underlying supply and demand dynamics is key to securing procurement strategies.
Read Full Report →
As a leading showcase for China's pharmaceutical raw materials on the international stage, CPHI China serves as an invaluable platform for collaborative scientific development.
Read Full Report →
Discover our newest synthetic bile acid techniques, high-recovery crystallization setups, and next-generation peptide-coupled bile salts.
Read Full Report →Exclusively manufactured and purified to support Swiss analytical laboratories and manufacturing facilities.
Technical, chemical, and logistical details about importing Cholic Acid derivatives to Switzerland.
Connect directly with our chemical engineering team to request sample batches, request targeted quotes, or receive direct technical support tailored for the Swiss pharmaceutical market.
Send Inquiry Now